Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Mexico approves Dengvaxia, world's first dengue vaccine

Dec. 10, 2015

Immunotope presents DENV universal vaccine candidates

Dec. 9, 2015

University of Pennsylvania patents rAAV expressing dual antibody constructs

Dec. 9, 2015

Sealife Pharma presents antibacterial agents

Dec. 7, 2015

SpsB inhibitors reported in RQx Pharmaceuticals patent

Dec. 7, 2015

EMA validates Gilead's MAA for fixed-dose sofosbuvir/velpatasvir

Dec. 7, 2015

Novavax initiates phase III trial of RSV F vaccine

Dec. 7, 2015

Intravenous Taigexyn achieves primary endpoint in phase III trial in community-acquired pneumonia

Dec. 7, 2015

Atea plans clinical development of new hepatitis C virus polymerase inhibitors

Dec. 3, 2015

Bristol-Myers Squibb discloses HCV NS5B inhibitors

Dec. 3, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...